Breaking News

ValiRx Signs Lease Deal with Nottingham Laboratories

New lab will allow ValiRx to conduct all testing in-house and create a more efficient translational drug development service for internal and third-party use.

ValiRx PLC, a life science company focused on early-stage cancer therapeutics and women’s health, has taken the lease on laboratory and office facilities at MediCity Nottingham as it embarks on the next stage of its strategy to launch a translational Contract Research Organization (tCRO).    MediCity is a medtech incubator and part of Pioneer Group, that provides resident businesses with access to a connected local and national biotech community, a strong pool of quality talent fro...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters